ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Fatty Liver/Adipose Tissue Dual-Targeting Nanoparticles with Heme Oxygenase-1 Inducer for Amelioration of Obesity, Obesity-Induced Type 2 Diabetes, and Steatohepatitis.

Juhyeong Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.